KU

Karthik Undar

Active Director Director DIN 09390917
DIN 09390917 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Karthik Undar

Data last updated:

Karthik Undar is a Director at Blue Hawk Life Sciences Private Limited (since 2021). The company operates in Pharma. Blue Hawk Life Sciences Private Limited reported revenue of ₹80,954 (FY 2024).

DIN 09390917
Primary Designation Director
Industry Pharma
First Appointment 09 Nov 2021
Oldest Company Age 4 yrs
Largest company Blue Hawk Life Sciences Private Limited · ₹80,954 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20212021₹80,954 (FY 2024)Active

Directorship timeline

Open interactive timeline →
Blue Hawk Life Sciences Private Limited
Premium access

Shareholding and investment profile for Karthik Undar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karthik Undar

Karthik Undar currently holds 1 directorship: Blue Hawk Life Sciences Private Limited (Director, since 09 Nov 2021, revenue ₹80,954 (FY 2024)).

Karthik Undar was first appointed on 09 Nov 2021 as Director at Blue Hawk Life Sciences Private Limited.

The current boards of Karthik Undar's companies include Borra Krishnaveni (Blue Hawk Life Sciences Private Limited), Siva Charan Hosur (Blue Hawk Life Sciences Private Limited), Swarajya Lakshmi Kristipati (Blue Hawk Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available